Title page for ETD etd-04162012-095021

Type of Document Master's Thesis
Author Hebert, Rebekah C.
Author's Email Address chebe38@tigers.lsu.edu
URN etd-04162012-095021
Title Repeatability of Prolactin Responses to Sulpiride in Mares and Geldings and the Effect of Pergolide and Cabergoline
Degree Master of Science (M.S.)
Department Animal Science (Animal, Dairy, & Poultry Sciences)
Advisory Committee
Advisor Name Title
Thompson, Donald L., Jr. Committee Chair
Bondioli, Kenneth R. Committee Member
Williams, Cathleen C. Committee Member
  • cabergoline
  • pergolide
  • sulpiride
  • prolactin
  • horse
Date of Defense 2012-03-30
Availability unrestricted
Four experiments were conducted in an effort to develop a method, based on prolactin secretion, for assessing the efficacy and duration of activity of dopaminergic agonists for the treatment of pituitary pars intermedia dysfunction (PPID) in horses. In the first experiment, prolactin response to a low dose of the dopamine antagonist, sulpiride, was generally repeatable in estrogen-primed geldings in winter over 8 every-other-day challenges. It was concluded that estrogen-primed, sulpiride-challenged geldings in winter could serve as a model for the study of potential dopaminergic drugs for the treatment of PPID in horses. The second experiment was performed in the summer with mares, and again tested the repeatability of the prolactin responses over a 30-day period. The responses in mares were generally repeatable, and there was no effect due to stage of the estrous cycle. It was concluded that mares could serve as a model for the study of potential dopaminergic drugs as well as geldings, and stage of the estrous cycle did not have to be taken into account. In the third experiment, two formulations of the dopamine agonist, pergolide, were tested (oral administration versus injection) against a single formulation of cabergoline (injected) and control injections (vehicle) for their efficacy to reduce unstimulated plasma prolactin concentrations in geldings. Oral pergolide reduced prolactin concentrations for a few hours, whereas injected pergolide suppressed prolactin concentrations for 24 hours. Cabergoline suppressed prolactin concentrations for up to 5.5 days. It was concluded that the injectable formulations had potential for further study as possible treatments for PPID in horses. The last experiment tested the efficacy of daily pergolide injection versus a single injection of cabergoline, for suppressing the prolactin secretion induced by low dose sulpiride injections in mares. Daily injection of pergolide suppressed prolactin responses as long as the injections were given, plus another 2 days. The single cabergoline injection suppressed prolactin responses for a minimum of 10 days. Based on these results, cabergoline in slow-release vehicle seems to provide an excellent possibility for administering dopaminergic activity to horses with PPID. Whether these results are directly applicable to PPID horses needs to be determined.
  Filename       Size       Approximate Download Time (Hours:Minutes:Seconds) 
 28.8 Modem   56K Modem   ISDN (64 Kb)   ISDN (128 Kb)   Higher-speed Access 
  Hebert_thesis.pdf 258.74 Kb 00:01:11 00:00:36 00:00:32 00:00:16 00:00:01

Browse All Available ETDs by ( Author | Department )

If you have questions or technical problems, please Contact LSU-ETD Support.